Search
About Wistar Research & Facilities Education & Training Technology Transfer Ways of Giving News & Information
         
 

Overview
Licensing Opportunities
Technologies
Research Tools
Patents
By Inventor
Material Transfers
Guidelines for Inventors
Contact Us
     
 

ANTI-p16 Monoclonal Antibodies (p16-25; p16-D8-1; p16-D8-2; p16-D8-3; p16-D8-4)

Inventors:    Meenhard Herlyn and Kapaettu Satyamoorthy

Tech ID:    HM-06RR

Description: p16 (INK4, MTS1, CDK4IN, CDKN2) is a major tumor suppressor gene, which is found deleted or mutated in many types of human cancers. Thus, presence or absence of p16 protein in human cancer cells is an important diagnostic criterion.

Origin: BALB/c mice were immunized with the human recombinant p16 fusion protein from E.coli. Fusion of spleen cells of immunized mice was done with the non-secreting mouse myeloma cell line P3x63Ag8.SP2/0.

All antibodies bind specifically to p16 in its recombinant or native form by ELISA, Western blotting. They also bind to p16 expressed by melanomas and nevi in situ.

Isotype: p16-25 (IgG1); p16-D8-1 (IgG1); p16-D8-2 (IgG1); p16-D8-3 (IgG1); p16-D8-4 (IgG1)

Application: Research, histochemistry, Western blotting

Keywords: Diagnosis of suppressor gene.

Contact:

Meryle J. Melnicoff, Ph.D.
Director, Business Development The Wistar Institute
Phone: (215) 898-0049
melnicoff@wistar.org

 

 

 

Meenhard Herlyn, D.V.M.

 

Contact Us

Meryle Melnicoff, PhD
Director, Business Development

George G. Pipia, PhD
Associate Director, Business Development

Christopher Harold Croft
Administrative Coordinator

Melanie Renee SaintMarc
Administrative Coordinator


  © 2007 The Wistar Institute | Terms of Use